-
EP2655312
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2655312
| EP2655312 - 3-ACYL-INGENOLS II [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.06.2018 Database last updated on 02.08.2024 | |
| Former | Examination is in progress Status updated on 18.11.2016 | Most recent event Tooltip | 01.06.2018 | Application deemed to be withdrawn | published on 04.07.2018 [2018/27] | Applicant(s) | For all designated states LEO LABORATORIES LIMITED 285 Cashel Road Crumlin Dublin 2 / IE | [2013/44] | Inventor(s) | 01 /
GRUE-SØRENSEN, Gunnar c/o LEO Pharma A/S Industriparken 55 DK-2750 Ballerup / DK | 02 /
LIANG, Xifu c/o LEO Pharma A/S Industriparken 55 DK-2750 Ballerup / DK | 03 /
HÖGBERG, Thomas c/o LEO Pharma A/S Industriparken 55 DK-2750 Ballerup / DK | 04 /
MÅNSSON, Kristoffer c/o LEO Pharma A/S Industriparken 55 DK-2750 Ballerup / DK | 05 /
VEDSØ, Per c/o LEO Pharma A/S Industriparken 55 DK-2750 Ballerup / DK | [2013/44] | Representative(s) | Leo Pharma A/S Industrieparken 55 2750 Ballerup / DK | [N/P] |
| Former [2013/44] | Jensen, Dorte Kold Leo Pharma A/S Patents Industriparken 55 2750 Ballerup / DK | Application number, filing date | 11808567.9 | 22.12.2011 | WO2011DK00155 | Priority number, date | US201061426375P | 22.12.2010 Original published format: US 201061426375 P | US201161494148P | 07.06.2011 Original published format: US 201161494148 P | [2013/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012083954 | Date: | 28.06.2012 | Language: | EN | [2012/26] | Type: | A1 Application with search report | No.: | EP2655312 | Date: | 30.10.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.06.2012 takes the place of the publication of the European patent application. | [2013/44] | Search report(s) | International search report - published on: | EP | 28.06.2012 | Classification | IPC: | C07C69/74, C07C69/75, C07C69/753, C07C229/56, C07C255/46, A61K31/215, A61K31/245, A61K31/277, A61P35/00, A61K31/216 | [2013/44] | CPC: |
C07C69/74 (EP,US);
A61K31/215 (US);
A61K31/235 (US);
A61K31/245 (US);
A61K31/277 (US);
A61K45/06 (US);
A61P17/00 (EP);
A61P17/08 (EP);
A61P17/12 (EP);
A61P31/20 (EP);
A61P35/00 (EP);
C07C229/56 (EP,US);
C07C229/58 (EP,US);
C07C229/64 (EP,US);
C07C233/54 (EP,US);
C07C255/46 (EP,US);
C07C69/013 (EP,US);
C07C69/75 (EP,US);
C07C69/753 (EP,US);
C07C69/76 (EP,US);
C07C69/78 (US);
C07C69/92 (EP,US);
C07C2601/02 (EP,US);
C07C2601/04 (EP,US);
C07C2601/08 (EP,US);
C07C2601/14 (EP,US);
C07C2601/16 (EP,US);
C07C2603/86 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/44] | Title | German: | 3-ACYL-INGENOLE II | [2013/44] | English: | 3-ACYL-INGENOLS II | [2013/44] | French: | 3-ACYL-INGÉNOLS II | [2013/44] | Entry into regional phase | 22.07.2013 | National basic fee paid | 22.07.2013 | Designation fee(s) paid | 22.07.2013 | Examination fee paid | Examination procedure | 27.06.2013 | Amendment by applicant (claims and/or description) | 22.07.2013 | Examination requested [2013/44] | 21.07.2016 | Despatch of a communication from the examining division (Time limit: M04) | 18.11.2016 | Reply to a communication from the examining division | 17.02.2017 | Despatch of a communication from the examining division (Time limit: M04) | 15.06.2017 | Reply to a communication from the examining division | 21.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 02.02.2018 | Application deemed to be withdrawn, date of legal effect [2018/27] | 28.02.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.07.2016 | Fees paid | Renewal fee | 27.12.2013 | Renewal fee patent year 03 | 29.12.2014 | Renewal fee patent year 04 | 28.12.2015 | Renewal fee patent year 05 | 27.12.2016 | Renewal fee patent year 06 | 02.01.2018 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]CA2541903 (PEPLIN RESEARCH PTY LTD [AU]) [A] 1-41 * page 30, lines 20-25; claims 4-8,11-16,18-20 *; | [A] - BLANCO-MOLINA ET AL, "Ingenol esters induce apoptosis in Jurkat cells through an AP-1 and NF-kappaB independent pathway", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, (20010101), vol. 8, no. 8, ISSN 1074-5521, pages 767 - 778, XP022574414 [A] 1-41 * Paragraph bridging the columns on page 773;;; compound 4 * | Examination | - Bernd Sorg ET AL, "Zur Chemie des Ingenols, II [1] Ester des Ingenols und des A 18 -Isoingenols On the Chemistry of Ingenol, II [1] Esters of Ingenol and Zl 7 -8 -Isoingenol", (19820101), pages 748 - 756, URL: https://www.degruyter.com/downloadpdf/j/znb.1982.37.issue-6/znb-1982-0615/znb-1982-0615.pdf, XP055406268 | - MAINIERI ET AL, "Synthesis of Sapintoxin D and N-Methylanthranilate-Based Fluorescent Bioprobes", NATURAL PRODUCT COMMUNICATIONS, NATURAL PRODUCT INC, US, (20070101), vol. 2, no. 4, ISSN 1934-578X, pages 375 - 379, XP009195485 | by applicant | WO9908994 | WO0193883 | WO0193884 | WO0193885 | WO2008131491 | WO2006063382 | AU2006201661 | WO0211743 | WO2007059584 | WO2010091472 | WO2008141078 | WO2007068963 | - H. GOTTA, Z. NATURFORSCHUNG, (1984), vol. 39B, pages 683 - 94 | - K. ABO, FITOTERAPIA, (1988), pages 244 - 46 | - S. ZAYED, J. CANCER RES. CLIN. ONCOL., (2001), vol. 127, pages 40 - 47 | - B. SORG, Z. NATURFORSCH., (1982), vol. 37B, pages 748 - 56 | - B. SORG, CARCINOGENESIS, (1987), vol. 8, pages 1 - 4 | - MARSTON, A., PLANTA MEDICA, (1983), vol. 47, pages 141 - 47 | - SORG, B., Z NATURFORSCHUNG, (1982), vol. 37B, pages 748 - 56 | - MAINIERI, F., NATURAL PRODUCT COMMUNICATION, (2007), vol. 2, no. 4, pages 375 - 379 | - BEEBY, P., TETRAHEDRON LETT., (1977), vol. 38, pages 3379 - 3382 | - HOSKINS, W.M., J. CHEM. SOC. PERKIN TRANS., (1977), vol. 1, pages 538 - 544 | - BOHLMANN, F., CHEM. BER., (1970), vol. 103, pages 561 - 563 | - SORG, B., Z. NATURFORSCH., (1982), vol. 37B, pages 748 - 756 | - ERSVAER, E. ET AL., TOXINS, (2010), vol. 2, pages 174 - 194 | - HAMPSON, P. ET AL., BLOOD, (2005), vol. 106, pages 1362 - 1368 | - COZZI, S.J., CANCER RES, (2006), vol. 66, pages 10083 - 10091 | - OGBOURNE, S.M. ET AL., CANCER RES, (2004), vol. 64, pages 2833 - 2839 | - CHALLACOMBE, J.M. ET AL., J IMMUNOL, (2006), vol. 177, pages 8123 - 8132 | - HAMPSON, P. ET AL., CANCER IMMUNOL IMMUNOTHER, (2008), vol. 57, pages 1241 - 1251 | - LE, T.T. ET AL., VACCCINE, (2009), vol. 27, pages 3053 - 3062 | - SORG, B., Z. NATURFORSCH., (1982), vol. 37B, pages 1640 - 47 | - B. SORG, Z. NATURFORSCH., (1982), vol. 37B, pages 748 - 756 | - OPFERKUCH, Z. NATURFORSCHUNG, (1981), vol. 36B, page 878 | - APPENDINO, EUR. J. ORG. CHEM., (1999), page 3413 | - NAM, N.-H., JOURNAL OF COMBINATORIAL CHEMISTRY, (2003), vol. 5, pages 479 - 545 | - OPFERKUCH, H. J, Z. NATURFORSCH., (1981), vol. 86B, pages 878 - 887 |